unknown
Stage
About
Aegerion Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapies for rare and ultra-rare lipid disorders, with a therapeutic focus on conditions such as homozygous familial hypercholesterolemia (HoFH).
Explore Aegerion Pharmaceuticals, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.